Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Growth factor signalling in the regulation of α-cell fate.

Kawamori D, Akiyama M, Hu J, Hambro B, Kulkarni RN.

Diabetes Obes Metab. 2011 Oct;13 Suppl 1:21-30. doi: 10.1111/j.1463-1326.2011.01442.x. Review.

PMID:
21824253
2.

The role of dysregulated glucagon secretion in type 2 diabetes.

D'Alessio D.

Diabetes Obes Metab. 2011 Oct;13 Suppl 1:126-32. doi: 10.1111/j.1463-1326.2011.01449.x. Review.

PMID:
21824266
3.

Regulation of glucagon secretion by zinc: lessons from the β cell-specific Znt8 knockout mouse model.

Hardy AB, Serino AS, Wijesekara N, Chimienti F, Wheeler MB.

Diabetes Obes Metab. 2011 Oct;13 Suppl 1:112-7. doi: 10.1111/j.1463-1326.2011.01451.x. Review.

PMID:
21824264
4.

Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.

Kumar DP, Asgharpour A, Mirshahi F, Park SH, Liu S, Imai Y, Nadler JL, Grider JR, Murthy KS, Sanyal AJ.

J Biol Chem. 2016 Mar 25;291(13):6626-40. doi: 10.1074/jbc.M115.699504. Epub 2016 Jan 12.

PMID:
26757816
5.

Glucagon-like peptide-1.

Doyle ME, Egan JM.

Recent Prog Horm Res. 2001;56:377-99. Review.

PMID:
11237222
6.

Insulin signaling in alpha cells modulates glucagon secretion in vivo.

Kawamori D, Kurpad AJ, Hu J, Liew CW, Shih JL, Ford EL, Herrera PL, Polonsky KS, McGuinness OP, Kulkarni RN.

Cell Metab. 2009 Apr;9(4):350-61. doi: 10.1016/j.cmet.2009.02.007.

7.

Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.

Omar BA, Andersen B, Hald J, Raun K, Nishimura E, Ahrén B.

Diabetes. 2014 Jan;63(1):101-10. doi: 10.2337/db13-0710. Epub 2013 Sep 23.

8.

Islet cell function: alpha and beta cells--partners towards normoglycaemia.

Göke B.

Int J Clin Pract Suppl. 2008 Mar;(159):2-7. doi: 10.1111/j.1742-1241.2007.01686.x. Review.

PMID:
18269435
9.

Inhibition of glucagon secretion.

Young A.

Adv Pharmacol. 2005;52:151-71. Review.

PMID:
16492545
10.

Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes.

Quesada I, Tudurí E, Ripoll C, Nadal A.

J Endocrinol. 2008 Oct;199(1):5-19. doi: 10.1677/JOE-08-0290. Epub 2008 Jul 31. Review.

11.

Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.

Bahrami J, Longuet C, Baggio LL, Li K, Drucker DJ.

Gastroenterology. 2010 Sep;139(3):857-68. doi: 10.1053/j.gastro.2010.05.006. Epub 2010 Jun 11.

PMID:
20546737
12.

Regulation of glucagon secretion by incretins.

Holst JJ, Christensen M, Lund A, de Heer J, Svendsen B, Kielgast U, Knop FK.

Diabetes Obes Metab. 2011 Oct;13 Suppl 1:89-94. doi: 10.1111/j.1463-1326.2011.01452.x. Review.

PMID:
21824261
13.

Diminished glucagon suppression after β-cell reduction is due to impaired α-cell function rather than an expansion of α-cell mass.

Meier JJ, Ueberberg S, Korbas S, Schneider S.

Am J Physiol Endocrinol Metab. 2011 Apr;300(4):E717-23. doi: 10.1152/ajpendo.00315.2010. Epub 2011 Feb 1.

14.

Molecular pathways underlying the pathogenesis of pancreatic alpha-cell dysfunction.

Kawamori D, Welters HJ, Kulkarni RN.

Adv Exp Med Biol. 2010;654:421-45. doi: 10.1007/978-90-481-3271-3_18. Review.

PMID:
20217508
15.

Delayed onset of hyperglycaemia in a mouse model with impaired glucagon secretion demonstrates that dysregulated glucagon secretion promotes hyperglycaemia and type 2 diabetes.

Gustavsson N, Seah T, Lao Y, Radda GK, Südhof TC, Han W.

Diabetologia. 2011 Feb;54(2):415-22. doi: 10.1007/s00125-010-1950-2. Epub 2010 Oct 27.

PMID:
20978738
16.

Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease.

Sandoval DA, D'Alessio DA.

Physiol Rev. 2015 Apr;95(2):513-48. doi: 10.1152/physrev.00013.2014. Review.

17.

Interleukin-6 regulates pancreatic alpha-cell mass expansion.

Ellingsgaard H, Ehses JA, Hammar EB, Van Lommel L, Quintens R, Martens G, Kerr-Conte J, Pattou F, Berney T, Pipeleers D, Halban PA, Schuit FC, Donath MY.

Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13163-8. doi: 10.1073/pnas.0801059105. Epub 2008 Aug 21.

18.

Impact of glucagon-like peptide-1 (7-36) amide, isosteviol and 5-aminoimidazole-4-carboxamide 1-β-d-ribofuranoside on leucine-mediated α-cell dysfunction.

Chen X, Hermansen K, Jeppesen PB.

Diabetes Obes Metab. 2012 Nov;14(11):1020-31. doi: 10.1111/j.1463-1326.2012.01633.x. Epub 2012 Jul 1.

PMID:
22747908
19.

Optimizing reduction in basal hyperglucagonaemia to repair defective glucagon counterregulation in insulin deficiency.

Farhy LS, McCall AL.

Diabetes Obes Metab. 2011 Oct;13 Suppl 1:133-43. doi: 10.1111/j.1463-1326.2011.01455.x. Review.

20.

A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets.

Marchetti P, Lupi R, Bugliani M, Kirkpatrick CL, Sebastiani G, Grieco FA, Del Guerra S, D'Aleo V, Piro S, Marselli L, Boggi U, Filipponi F, Tinti L, Salvini L, Wollheim CB, Purrello F, Dotta F.

Diabetologia. 2012 Dec;55(12):3262-72. doi: 10.1007/s00125-012-2716-9. Epub 2012 Sep 11.

PMID:
22965295
Items per page

Supplemental Content

Write to the Help Desk